GRAY insider filings
CalciMedica, Inc. — 12 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-03-27. Screen GRAY transaction legs live →
Insider transaction summary — last 90 days
No insider filings (Forms 3/4/5) for GRAY between 2026-07-10 and 2026-10-08. The table below lists the most recent filings on record.
Recent insider filings — CalciMedica, Inc.
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2023-03-27 | 4 | Zamiri Parisa — Chief Medical Officer | Disposition to issuer (D): 42,771 · Tax withholding (F): 17,901 @ $5.50 · Disposition to issuer (D): 42,771 (derivative) | EDGAR |
| 2023-03-27 | 4 | Sauer Dirk — Director | Disposition to issuer (D): 1,429 · Disposition to issuer (D): 1,429 (derivative) | EDGAR |
| 2023-03-27 | 4 | Guerard Frederic — Chief Executive Officer, Director | Disposition to issuer (D): 83,705 · Tax withholding (F): 20,383 @ $5.50 · Disposition to issuer (D): 83,705 (derivative) | EDGAR |
| 2023-03-27 | 4 | ACKERMANN CHRISTINA — Director | Disposition to issuer (D): 1,429 · Disposition to issuer (D): 1,429 (derivative) | EDGAR |
| 2023-03-27 | 4 | EASTLAND JULIA MARIE — Director | Disposition to issuer (D): 1,429 · Disposition to issuer (D): 1,429 (derivative) | EDGAR |
| 2023-03-27 | 4 | BREUIL ROBERT S — Chief Financial Officer | Disposition to issuer (D): 36,657 · Tax withholding (F): 12,677 @ $5.50 · Disposition to issuer (D): 36,657 (derivative) | EDGAR |
| 2023-03-27 | 4 | BJERKHOLT ERIC — Director | Disposition to issuer (D): 1,429 · Disposition to issuer (D): 1,429 (derivative) | EDGAR |
| 2023-03-27 | 4 | SHAFFER CHRISTY L — Director | Disposition to issuer (D): 1,429 · Disposition to issuer (D): 1,429 (derivative) | EDGAR |
| 2023-03-15 | 4 | BREUIL ROBERT S — Chief Financial Officer | Option exercise (M): 5,000 · Tax withholding (F): 1,730 @ $0.58 · Option exercise (M): 5,000 (derivative) @ $0 | EDGAR |
| 2023-03-06 | 4 | Zamiri Parisa — Chief Medical Officer | Option exercise (M): 120,655 · Tax withholding (F): 42,894 @ $0.57 · Option exercise (M): 9,375 (derivative) @ $0 · Option exercise (M): 83,155 (derivative) @ $0 · Option exercise (M): 28,125 (derivative) @ $0 | EDGAR |
| 2023-03-06 | 4 | Guerard Frederic — Chief Executive Officer, Director | Option exercise (M): 315,496 · Tax withholding (F): 89,344 @ $0.57 · Option exercise (M): 28,125 (derivative) @ $0 · Option exercise (M): 221,746 (derivative) @ $0 · Option exercise (M): 65,625 (derivative) @ $0 | EDGAR |
| 2023-03-06 | 4 | BREUIL ROBERT S — Chief Financial Officer | Option exercise (M): 121,217 · Tax withholding (F): 49,434 @ $0.57 · Option exercise (M): 9,937 (derivative) @ $0 · Option exercise (M): 83,155 (derivative) @ $0 · Option exercise (M): 28,125 (derivative) @ $0 | EDGAR |
Recent 8-K events — CalciMedica, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-09-30 | 8-K | 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-09-16 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-09-02 | 8-K | 8.01 — Other Events | EDGAR |
| 2026-08-27 | 8-K | 5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-20 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers 5.07 — Submission of Matters to a Vote of Security Holders 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-08-11 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-07 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-06-24 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-24 | 8-K | 1.01 — Entry into a Material Definitive Agreement 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-05-12 | 8-K | 2.02 — Results of Operations and Financial Condition 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=GRAY returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →